Real-world success of de-escalating upadacitinib induction dosing in ulcerative colitis is predicted by steroid-free clinical and biochemical remission, not induction duration.

Journal: Crohn's & colitis 360 •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Dalal RM, Rotondo-Trivette S, Mason AR, et al. (2026). "Real-world success of de-escalating upadacitinib induction dosing in ulcerative colitis is predicted by steroid-free clinical and biochemical remission, not induction duration.". Crohn's & colitis 360. https://doi.org/10.1093/crocol/otag111